title: First experiences with the use of CASA in mammary carcinoma.
abstract: The expression of the tumor marker CASA (cancer associated serum antigen) was studied in patients with mammary carcinoma; increased values were almost exclusively seen in cases of manifest metastasis. No correlation existed between tumor stage, lymph node involvement and grading. Marker levels were tested by means of enzyme-immune-assay of the firm medac (Hamburg), with a cut-off value set at 4 U/ml.
authors.affiliation: Department of Obstetrics and Gynecology, Ernst-Moritz-Arndt University, Greifswald, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Weise
authors.forename: M
authors.initials: M
authors.lastname: Meisel
authors.forename: W
authors.initials: W
authors.lastname: Straube
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008207:Lymphatic Metastasis; D018396:Mucin-1 / Q000097:blood*; D009367:Neoplasm Staging
chemical_list: D014408:Biomarkers, Tumor; D018396:Mucin-1